Optimal designs for active controlled dose finding trials with efficacy-toxicity outcomes

Holger Dette, Katrin Kettelhake, Kirsten Schorning +2

Nonlinear regression models addressing both efficacy and toxicity outcomes are increasingly used in dose-finding trials, such as in pharmaceutical drug development. However, resear…